These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21050504)

  • 1. Peripartum factors predicting the need for increased doses of postpartum rhesus immune globulin.
    Leyenaar L; Allen VM; Robinson HE; Parsons M; Van den Hof MC
    J Obstet Gynaecol Can; 2010 Aug; 32(8):739-44. PubMed ID: 21050504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of Rh alloimmunization.
    Fung Kee Fung K; Eason E; Crane J; Armson A; De La Ronde S; Farine D; Keenan-Lindsay L; Leduc L; Reid GJ; Aerde JV; Wilson RD; Davies G; Désilets VA; Summers A; Wyatt P; Young DC;
    J Obstet Gynaecol Can; 2003 Sep; 25(9):765-73. PubMed ID: 12970812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No. 133-Prevention of Rh Alloimmunization.
    Fung KFK; Eason E
    J Obstet Gynaecol Can; 2018 Jan; 40(1):e1-e10. PubMed ID: 29274715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-D administration after spontaneous miscarriage for preventing Rhesus alloimmunisation.
    Karanth L; Jaafar SH; Kanagasabai S; Nair NS; Barua A
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009617. PubMed ID: 23543581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective quantification of fetomaternal hemorrhage with dilation and evacuation procedures.
    Hsia JK; Schimmoeller NR; Cansino CD; Hou MY; Jensen HM; Creinin MD
    Contraception; 2019 May; 99(5):281-284. PubMed ID: 30500335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of fetomaternal hemorrhage in postpartum patients with indication for administration of anti-D immunoglobulin].
    Baiochi E; Camano L; Bordin JO
    Cad Saude Publica; 2005; 21(5):1357-65. PubMed ID: 16158140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of Rh (D) alloimmunization in Rh (D) negative women in pregnancy and after birth of Rh (D) positive infant].
    L'ubuský M; Procházka M; Krejcová L; Vetr M; Santavý J; Kudela M
    Ceska Gynekol; 2006 May; 71(3):173-9. PubMed ID: 16768042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-D administration in pregnancy for preventing Rhesus alloimmunisation.
    Crowther CA; Middleton P; McBain RD
    Cochrane Database Syst Rev; 2013 Feb; (2):CD000020. PubMed ID: 23450526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The experience and effectiveness of the Nova Scotia Rh program, 1964-84.
    Baskett TF; Parsons ML; Peddle LJ
    CMAJ; 1986 Jun; 134(11):1259-61. PubMed ID: 3011235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice Bulletin No. 181: Prevention of Rh D Alloimmunization.
    Obstet Gynecol; 2017 Aug; 130(2):e57-e70. PubMed ID: 28742673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practice Bulletin No. 181 Summary: Prevention of Rh D Alloimmunization.
    Obstet Gynecol; 2017 Aug; 130(2):481-483. PubMed ID: 28742667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failures of intravenous Rh immune globulin prophylaxis: an analysis of the reasons for such failures.
    Bowman JM; Pollock JM
    Transfus Med Rev; 1987 Aug; 1(2):101-12. PubMed ID: 2856541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postpartum Rh immunoprophylaxis.
    Sandler SG; Gottschall JL
    Obstet Gynecol; 2012 Dec; 120(6):1428-38. PubMed ID: 23168770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre trial of antepartum low-dose anti-D immunoglobulin.
    Lee D; Rawlinson VI
    Transfus Med; 1995 Mar; 5(1):15-9. PubMed ID: 7767393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline No. 448: Prevention of Rh D Alloimmunization.
    Fung-Kee-Fung K; Wong K; Walsh J; Hamel C; Clarke G
    J Obstet Gynaecol Can; 2024 Apr; 46(4):102449. PubMed ID: 38553007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing rhesus isoimmunization. Antepartum Rh immune globulin prophylaxis versus a sensitive test for risk identification.
    Hensleigh PA
    Am J Obstet Gynecol; 1983 Aug; 146(7):749-55. PubMed ID: 6307052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Rh isoimmunization after spontaneous, massive fetomaternal hemorrhage.
    Graham EM; Freedman LJ; Forouzan I; Morgan MA
    South Med J; 1996 Sep; 89(9):911-4. PubMed ID: 8790318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACOG practice bulletin. Prevention of Rh D alloimmunization. Number 4, May 1999 (replaces educational bulletin Number 147, October 1990). Clinical management guidelines for obstetrician-gynecologists. American College of Obstetrics and Gynecology.
    Int J Gynaecol Obstet; 1999 Jul; 66(1):63-70. PubMed ID: 10458556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular versus intravenous anti-D for preventing Rhesus alloimmunization during pregnancy.
    Okwundu CI; Afolabi BB
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007885. PubMed ID: 23440818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhesus Negative Woman Transfused With Rhesus Positive Blood: Subsequent Normal Pregnancy Without Anti D production.
    Maya ET; Buntugu KA; Pobee F; Srofenyoh EK
    Ghana Med J; 2015 Mar; 49(1):60-3. PubMed ID: 26339087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.